| 000 | 00953 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250512201355.0 | ||
| 264 | 0 | _c19820814 | |
| 008 | 198208s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(82)92541-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNoah, N D | |
| 245 | 0 | 0 |
_aMeasles vaccine versus inosiplex. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 1982 |
||
| 300 |
_a1420 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Letter | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInosine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aInosine Pranobex _xtherapeutic use |
| 650 | 0 | 4 |
_aMeasles Vaccine _xtherapeutic use |
| 650 | 0 | 4 |
_aSubacute Sclerosing Panencephalitis _xprevention & control |
| 700 | 1 | _aMiller, C L | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8286 _gp. 1420 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(82)92541-7 _zAvailable from publisher's website |
| 999 |
_c6178029 _d6178029 |
||